Lisa Harrington

As 2018 winds down, awards season is in full swing! Last week we announced that Hyman, Phelps & McNamara, P.C. (“HP&M”) was tapped by U.S. News and Best Lawyers as the recipient of the 2019 “Law Firm of the Year in FDA Law” award.  This …

Hyman, Phelps & McNamara, P.C. (“HP&M”) has once again been ranked as a “Tier 1” law firm in the area of “FDA Law” (both nationally and in Washington, D.C.) by the folks over at U.S. News & World Report, who teamed up with Best Lawyers …

During the 34th annual National Association of State Controlled Substances Authorities (“NASCSA”) conference in Scottsdale, Arizona, Hyman, Phelps & McNamara, P.C. (“HP&M”) Director Larry Houck was honored with the organization’s 2018 President’s Award. NASCSA provides a forum for state, federal and local regulators, healthcare professionals, …

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference websitehttp://www.afia.org/afiaevents

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website.

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

June 26, The Patient’s Assessment of the Patient-Focused Drug Development Meeting Initiatives June 27, Global Rare Disease Town Hall For more information visit conference website

For more information see conference website

For more information visit conference website

For more information visit conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For more information see conference website

For  more information see conference website

For more information see conference website

For more information see conference website

For more information, visit conference website